Yüklüyor......
Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer
INTRODUCTION: Adjuvant platinum based chemotherapy is accepted as standard of care in stage II and III non-small cell lung cancer (NSCLC) patients and is often considered in patients with stage IB disease who have tumors ≥ 4 cm. The survival advantage is modest with approximately 5% at 5 years. AREA...
Kaydedildi:
| Yayımlandı: | Expert Rev Anticancer Ther |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6863145/ https://ncbi.nlm.nih.gov/pubmed/29168933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737140.2018.1409624 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|